Pulmonx Corp reports results for the quarter ended December 31 - Earnings Summary

Pulmonx

19/02/2025 22:02

* Pulmonx Corp  LUNG.OQ  reported a quarterly adjusted loss
of 33
cents​​ per share for the quarter ended December 31, higher than
the same quarter last year, when the company reported EPS of -36
cents.  The mean expectation of six analysts for the quarter was
for a loss of 45 cents per share. Wall Street expected
results to range from -47 cents to -41 cents per share.
    * Revenue rose 23.3% to $23.77 million from a year ago;
analysts
expected $22.29 million. 
    * Pulmonx Corp's reported EPS for the quarter was a loss
of 33
cents​.
    * The company reported a quarterly loss of $13.18 million.
    * Pulmonx Corp shares had risen by 2.9% this quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "buy"

Wall Street's median 12-month price target for Pulmonx Corp is
$11.00 
This summary was machine generated from LSEG data February 19 at
10:02 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2024      -0.45          -0.33          Beat
 Sep. 30 2024      -0.45          -0.36          Beat
 Jun. 30 2024      -0.43          -0.35          Beat
 Mar. 31 2024      -0.46          -0.36          Beat